DM
AERI

Deerfield Management’s Aerie Pharmaceuticals AERI Stock Holding History

Deerfield Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-103,800
Closed -$2.51M – 103
2019
Q4 		$2.51M Buy
+103,800
New +$2.15M 0.08% 71

Deerfield Management's AERI Position: Q4 2022 in Review

Deerfield Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 4,855,005 shares — an estimated $73.5M sold.

Deerfield Management first reported a position in AERI in Q4 2013 and held it in 36 quarters. The position peaked at $94.8M in Q3 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Deerfield Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Deerfield Management sold 4,855,005 Aerie Pharmaceuticals shares in Q4 2022, an estimated $73.5M.
  • Deerfield Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 36 quarters.
  • Deerfield Management's Aerie Pharmaceuticals position peaked at $94.8M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Deerfield Management's 13F filing for Q4 2022, filed 14 Feb 2023.